The couple's conflicting filming schedules got in the way throughout 2024, as they tell PEOPLE they "barely saw each other ...
Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...
Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...
With reports of Alex Bregman signing a three-year deal with the Red Sox, Thursday is a great day for Boston baseball.
WORCESTER — Fifteen people were displaced after flames spread from one multi-family house to another on Stoneland Road early ...
The board of Roche Holding AG ( VTX:ROG ) has announced that it will be paying its dividend of CHF9.70 on the 31st ...
Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.
Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results